This is a Validated Antibody Database (VAD) review about human CCNE2, based on 60 published articles (read how Labome selects the articles), using CCNE2 antibody in all methods. It is aimed to help Labome visitors find the most suited CCNE2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCNE2 synonym: CYCE2

Knockout validation
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 3c
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4132) was used in western blot knockout validation on mouse samples (fig 3c). Mol Pharmacol (2017) ncbi
Abcam
domestic rabbit monoclonal (EP454Y)
  • western blot; human; 1:2000; loading ...; fig 6a
Abcam CCNE2 antibody (Abcam, ab40890) was used in western blot on human samples at 1:2000 (fig 6a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (E142)
  • western blot; human; loading ...; fig 2j
Abcam CCNE2 antibody (Abcam, ab32103) was used in western blot on human samples (fig 2j). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (E142)
  • flow cytometry; mouse; loading ...; fig 3e
In order to elucidate how Zfp36l1 and Zfp36l2 regulate the thymic beta-Selection checkpoint, Abcam CCNE2 antibody (Abcam, E142) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2016) ncbi
domestic rabbit monoclonal (E142)
  • western blot; human; loading ...; fig s2a
In order to examine the role of gene overexpression on chromosome instability, Abcam CCNE2 antibody (Abcam, ab32103) was used in western blot on human samples (fig s2a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (E142)
  • western blot; human; 1:1000; fig 3
Abcam CCNE2 antibody (Abcam, ab32103) was used in western blot on human samples at 1:1000 (fig 3). J Hematol Oncol (2015) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4132) was used in western blot on human samples (fig 2c). Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5b). Pharmaceutics (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 2f
Cell Signaling Technology CCNE2 antibody (CST, 4132) was used in western blot on human samples (fig 2f). Mol Cancer (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 3e
Cell Signaling Technology CCNE2 antibody (Cell Signal, 4129) was used in western blot on human samples (fig 3e). Clin Transl Med (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples at 1:1000 (fig 3b). Clin Transl Med (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5e
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 5e). Oncogene (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples (fig 4a). Cell Death Dis (2021) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology CCNE2 antibody (CST, 4129) was used in western blot on human samples (fig 5a). Breast Cancer Res (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology CCNE2 antibody (CST, 4132) was used in western blot on human samples (fig 5a). Breast Cancer Res (2021) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; loading ...; fig 4b
Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in western blot on mouse samples (fig 4b). PLoS ONE (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4132) was used in western blot on human samples (fig 1a). Breast Cancer Res (2019) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples (fig 5a). Cancer Res (2019) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; loading ...; fig s12f
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on mouse samples at 1:1000 (fig s12f). Science (2019) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig s1f
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129S) was used in western blot on human samples at 1:1000 (fig s1f). EMBO J (2018) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; loading ...; fig 2h
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on mouse samples (fig 2h). Cancer Res (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 5
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5). Exp Neurol (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 4c
Cell Signaling Technology CCNE2 antibody (cell signalling, 4132) was used in western blot on human samples at 1:1000 (fig 4c). Int J Oncol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples at 1:1000 (fig 3c). Am J Cancer Res (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129s) was used in western blot on human samples at 1:1000 (fig 3c). Am J Cancer Res (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 2c
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 2c). J Biol Chem (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig S1A
Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in western blot on human samples (fig S1A). Mol Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4A
Cell Signaling Technology CCNE2 antibody (Cell signaling, 4132) was used in western blot on human samples (fig 4A). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples . Neoplasia (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig s3b
Cell Signaling Technology CCNE2 antibody (Cell signaling, 4129) was used in western blot on human samples (fig s3b). Nat Commun (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1d
In order to research the role of polo like kinase 1 in MTOR complex 1 and autophagy, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 1d). Autophagy (2017) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 3c
In order to look for potential tumor suppressors and examine their function as cell cycle modulators and investigate their impact on the cyclin family of proteins and cyclin dependent kinases, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4132) was used in western blot knockout validation on mouse samples (fig 3c). Mol Pharmacol (2017) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology CCNE2 antibody (Cell Signaling Tech, 4129) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; loading ...; fig s3b
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:1000 (fig s3b). Oncogene (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
Cell Signaling Technology CCNE2 antibody (Cell signaling, 4132) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
In order to study the role of Skp2 in paclitaxel-resistant prostate cancer cells, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4132) was used in western blot on human samples (fig 5a). Oncol Rep (2016) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; fig s1
Cell Signaling Technology CCNE2 antibody (Cell Signal, 4129) was used in western blot on mouse samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples . Nucleic Acids Res (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 4
Cell Signaling Technology CCNE2 antibody (Cell signaling, 4129S) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s3e
Cell Signaling Technology CCNE2 antibody (CST, 4132) was used in western blot on human samples (fig s3e). Biochim Biophys Acta (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 1b
In order to study quinacrine-induced apoptosis, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 1b). Biochem Pharmacol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; loading ...; fig s2d
In order to study the role of DCAF1 in T-cell function through p53-dependent and -independent mechanisms, Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in western blot on mouse samples at 1:1000 (fig s2d). Nat Commun (2016) ncbi
mouse monoclonal (HE12)
  • immunohistochemistry - paraffin section; human; fig 1a
Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in immunohistochemistry - paraffin section on human samples (fig 1a). BMC Cancer (2015) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4132) was used in western blot on human samples at 1:1000 (fig 1). Nat Cell Biol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:1000; fig 3
In order to investigate factors that control PHD1 activity, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:1000 (fig 3). J Cell Sci (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
In order to characterize modulation of microtubular structure and HSP90alpha chaperone activity against prostate cancer by 4-hydroxybenzoic acid derivatives as HDAC6-specific inhibitors, Cell Signaling Technology CCNE2 antibody (Cell signaling, 4129) was used in western blot on human samples (fig 5). Biochem Pharmacol (2016) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 3b
In order to study MARCKS signaling and how it expresses endothelial cell proliferation and vascular smooth muscle through a KIS-, p27kip1- dependent mechanism, Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 3b). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 4c
In order to report that expression of HIF2alpha is regulated by the deubiquitylase Cezanne in an E2F1-dependent manner, Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in western blot on human samples (fig 4c). J Cell Sci (2015) ncbi
mouse monoclonal (HE12)
  • western blot; mouse; 1:1000; fig 2
Cell Signaling Technology CCNE2 antibody (Cell Signaling Tech, 4129) was used in western blot on mouse samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:750; fig 2
In order to investigate the contribution of cyclobutane pyrimidine dimers to UVB-induced changes of gene expression, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:750 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology CCNE2 antibody (Cell signaling, 4129) was used in western blot on human samples (fig 5). Nucleic Acids Res (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:500
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129S) was used in western blot on human samples at 1:500. Br J Pharmacol (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 1
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 5
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 5). Int J Mol Sci (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study CREB in acute myeloid leukemia, Cell Signaling Technology CCNE2 antibody (Cell Signaling, HE12) was used in western blot on human samples . Leukemia (2015) ncbi
mouse monoclonal (HE12)
  • western blot; human; fig 6e
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technologies, 4129) was used in western blot on human samples (fig 6e). Mol Cell (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples . J Natl Cancer Inst (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to evaluate large subunit ribosomal proteins as therapeutic targets for melanoma, Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples . Pigment Cell Melanoma Res (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; loading ...; fig 6e
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples (fig 6e). Mol Endocrinol (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
In order to study the involvement of RASSF1A inactivation in carcinogenesis, Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples . Mol Cell Biol (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human
Cell Signaling Technology CCNE2 antibody (Cell Signaling Technology, 4129) was used in western blot on human samples . Cell Signal (2014) ncbi
mouse monoclonal (HE12)
  • western blot; human; 1:3000
Cell Signaling Technology CCNE2 antibody (Cell Signaling, 4129) was used in western blot on human samples at 1:3000. Exp Hematol (2012) ncbi
Articles Reviewed
  1. Fei X, Wu X, Dou Y, Sun K, Guo Q, Zhang L, et al. TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I. Mol Ther Oncolytics. 2022;26:413-428 pubmed publisher
  2. Deshmukh D, Xu J, Yang X, Shimelis H, Fang S, Qiu Y. Regulation of p27 (Kip1) by Ubiquitin E3 Ligase RNF6. Pharmaceutics. 2022;14: pubmed publisher
  3. Liu X, Liu Y, Liu Z, Lin C, Meng F, Xu L, et al. CircMYH9 drives colorectal cancer growth by regulating serine metabolism and redox homeostasis in a p53-dependent manner. Mol Cancer. 2021;20:114 pubmed publisher
  4. Zhang Y, He L, Huang L, Yao S, Lin N, Li P, et al. Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathway. Clin Transl Med. 2021;11:e503 pubmed publisher
  5. Sakai H, Kawakami H, Teramura T, Onodera Y, Somers E, Furuuchi K, et al. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer. Clin Transl Med. 2021;11:e454 pubmed publisher
  6. Fischietti M, Eckerdt F, Blyth G, Arslan A, Mati W, Oku C, et al. Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma. Oncogene. 2021;40:3273-3286 pubmed publisher
  7. Dong C, Jiang T, Yin H, Song H, Zhang Y, Geng H, et al. LMNB2 promotes the progression of colorectal cancer by silencing p21 expression. Cell Death Dis. 2021;12:331 pubmed publisher
  8. Kaminska K, Akrap N, Staaf J, Alves C, Ehinger A, Ebbesson A, et al. Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer. Breast Cancer Res. 2021;23:26 pubmed publisher
  9. Chen A, Santana A, Doudican N, Roudiani N, Laursen K, Therrien J, et al. MAGE-A3 is a prognostic biomarker for poor clinical outcome in cutaneous squamous cell carcinoma with perineural invasion via modulation of cell proliferation. PLoS ONE. 2020;15:e0241551 pubmed publisher
  10. Huang S, Zhang C, Sun C, Hou Y, Zhang Y, Tam N, et al. Obg-like ATPase 1 (OLA1) overexpression predicts poor prognosis and promotes tumor progression by regulating P21/CDK2 in hepatocellular carcinoma. Aging (Albany NY). 2020;12:3025-3041 pubmed publisher
  11. Patel H, Tao N, Lee K, Huerta M, Arlt H, Mullarkey T, et al. Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors. Breast Cancer Res. 2019;21:146 pubmed publisher
  12. Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging (Albany NY). 2019;11:7830-7846 pubmed publisher
  13. Wang Z, Feng X, Molinolo A, Martin D, Vitale Cross L, Nohata N, et al. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer. Cancer Res. 2019;: pubmed publisher
  14. Chakraborty A, Laukka T, Myllykoski M, Ringel A, Booker M, Tolstorukov M, et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science. 2019;363:1217-1222 pubmed publisher
  15. Allan L, Skowyra A, Rogers K, Zeller D, Clarke P. Atypical APC/C-dependent degradation of Mcl-1 provides an apoptotic timer during mitotic arrest. EMBO J. 2018;37: pubmed publisher
  16. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  17. Oblinger J, Burns S, Huang J, Pan L, Ren Y, Shen R, et al. Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation. Exp Neurol. 2018;299:299-307 pubmed publisher
  18. Li X, Liu F, Lin B, Luo H, Liu M, Wu J, et al. miR?150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma. Int J Oncol. 2017;: pubmed publisher
  19. Jiang J, Chen X, Liu H, Shao J, Xie R, Gu P, et al. Polypyrimidine Tract-Binding Protein 1 promotes proliferation, migration and invasion in clear-cell renal cell carcinoma by regulating alternative splicing of PKM. Am J Cancer Res. 2017;7:245-259 pubmed
  20. Juhasz A, Markel S, Gaur S, Liu H, Lu J, Jiang G, et al. NADPH oxidase 1 supports proliferation of colon cancer cells by modulating reactive oxygen species-dependent signal transduction. J Biol Chem. 2017;292:7866-7887 pubmed publisher
  21. Wyatt H, Laister R, Martin S, Arrowsmith C, West S. The SMX DNA Repair Tri-nuclease. Mol Cell. 2017;65:848-860.e11 pubmed publisher
  22. Zhu Y, Kawaguchi K, Kiyama R. Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors. PLoS ONE. 2017;12:e0171390 pubmed publisher
  23. Zhai S, Liu C, Zhang L, Zhu J, Guo J, Zhang J, et al. PLCE1 Promotes Esophageal Cancer Cell Progression by Maintaining the Transcriptional Activity of Snail. Neoplasia. 2017;19:154-164 pubmed publisher
  24. Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M, et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290 pubmed publisher
  25. Ruf S, Heberle A, Langelaar Makkinje M, Gelino S, Wilkinson D, Gerbeth C, et al. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy. Autophagy. 2017;13:486-505 pubmed publisher
  26. Choiniere J, Wu J, Wang L. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins. Mol Pharmacol. 2017;91:189-196 pubmed publisher
  27. Zhang Y, Zhang Y, Zhong C, Xiao F. Cr(VI) induces premature senescence through ROS-mediated p53 pathway in L-02 hepatocytes. Sci Rep. 2016;6:34578 pubmed publisher
  28. Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, et al. Ecotropic viral integration site 1, a novel oncogene in prostate cancer. Oncogene. 2017;36:1573-1584 pubmed publisher
  29. Vogel K, Bell L, Galloway A, Ahlfors H, Turner M. The RNA-Binding Proteins Zfp36l1 and Zfp36l2 Enforce the Thymic ?-Selection Checkpoint by Limiting DNA Damage Response Signaling and Cell Cycle Progression. J Immunol. 2016;197:2673-2685 pubmed publisher
  30. Duffy S, Fam H, Wang Y, Styles E, Kim J, Ang J, et al. Overexpression screens identify conserved dosage chromosome instability genes in yeast and human cancer. Proc Natl Acad Sci U S A. 2016;113:9967-76 pubmed publisher
  31. Chen X, Stauffer S, Chen Y, Dong J. Ajuba Phosphorylation by CDK1 Promotes Cell Proliferation and Tumorigenesis. J Biol Chem. 2016;291:14761-72 pubmed publisher
  32. Yang Y, Lu Y, Wang L, Mizokami A, Keller E, Zhang J, et al. Skp2 is associated with paclitaxel resistance in prostate cancer cells. Oncol Rep. 2016;36:559-66 pubmed publisher
  33. Ho T, Guilbaud G, Blow J, Sale J, Watson C. The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability. Cell Rep. 2016;15:724-734 pubmed publisher
  34. Mitxelena J, Apraiz A, Vallejo Rodríguez J, Malumbres M, Zubiaga A. E2F7 regulates transcription and maturation of multiple microRNAs to restrain cell proliferation. Nucleic Acids Res. 2016;: pubmed
  35. Tang Y, Huang L, Lin W, Wang L, Tian Y, Shi D, et al. Butein inhibits cell proliferation and induces cell cycle arrest in acute lymphoblastic leukemia via FOXO3a/p27kip1 pathway. Oncotarget. 2016;7:18651-64 pubmed publisher
  36. Cott C, Thuenauer R, Landi A, Kühn K, Juillot S, Imberty A, et al. Pseudomonas aeruginosa lectin LecB inhibits tissue repair processes by triggering β-catenin degradation. Biochim Biophys Acta. 2016;1863:1106-18 pubmed publisher
  37. Preet R, Siddharth S, Satapathy S, Das S, Nayak A, Das D, et al. Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade. Biochem Pharmacol. 2016;105:23-33 pubmed publisher
  38. Guo Z, Kong Q, Liu C, Zhang S, Zou L, Yan F, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016;7:10307 pubmed publisher
  39. Lee E, Jin D, Lee B, Kim Y, Han J, Shim Y, et al. Negative effect of cyclin D1 overexpression on recurrence-free survival in stage II-IIIA lung adenocarcinoma and its expression modulation by vorinostat in vitro. BMC Cancer. 2015;15:982 pubmed publisher
  40. Guo X, Wang X, Wang Z, Banerjee S, Yang J, Huang L, et al. Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis. Nat Cell Biol. 2016;18:202-12 pubmed publisher
  41. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  42. Seidel C, Schnekenburger M, Mazumder A, Teiten M, Kirsch G, Dicato M, et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer. Biochem Pharmacol. 2016;99:31-52 pubmed publisher
  43. Yu D, Makkar G, Dong T, Strickland D, Sarkar R, Monahan T. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism. PLoS ONE. 2015;10:e0141397 pubmed publisher
  44. Suwei D, Liang Z, Zhimin L, Ruilei L, Yingying Z, Zhen L, et al. NLK functions to maintain proliferation and stemness of NSCLC and is a target of metformin. J Hematol Oncol. 2015;8:120 pubmed publisher
  45. Moniz S, Bandarra D, Biddlestone J, Campbell K, Komander D, Bremm A, et al. Cezanne regulates E2F1-dependent HIF2α expression. J Cell Sci. 2015;128:3082-93 pubmed publisher
  46. Cardona M, López J, Serafín A, Rongvaux A, Inserte J, García Dorado D, et al. Executioner Caspase-3 and 7 Deficiency Reduces Myocyte Number in the Developing Mouse Heart. PLoS ONE. 2015;10:e0131411 pubmed publisher
  47. Boros G, Miko E, Muramatsu H, Weissman D, Emri E, van der Horst G, et al. Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA. PLoS ONE. 2015;10:e0131141 pubmed publisher
  48. Ahn J, Kim S, Na W, Baek S, Kim J, Min K, et al. SERBP1 affects homologous recombination-mediated DNA repair by regulation of CtIP translation during S phase. Nucleic Acids Res. 2015;43:6321-33 pubmed publisher
  49. Ishihara S, Yasuda M, Ishizu A, Ishikawa M, Shirato H, Haga H. Activating transcription factor 5 enhances radioresistance and malignancy in cancer cells. Oncotarget. 2015;6:4602-14 pubmed
  50. Barrichon M, Hadi T, Wendremaire M, Ptasinski C, Seigneuric R, Marcion G, et al. Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells. Br J Pharmacol. 2015;172:2974-90 pubmed publisher
  51. Su C, Zhang C, Tecle A, Fu X, He J, Song J, et al. Tudor staphylococcal nuclease (Tudor-SN), a novel regulator facilitating G1/S phase transition, acting as a co-activator of E2F-1 in cell cycle regulation. J Biol Chem. 2015;290:7208-20 pubmed publisher
  52. Li Z, Xiao J, Hu K, Wang G, Li M, Zhang J, et al. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma. Int J Mol Sci. 2015;16:2294-306 pubmed publisher
  53. Chae H, Mitton B, Lacayo N, Sakamoto K. Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA. Leukemia. 2015;29:1379-89 pubmed publisher
  54. Gasser J, Inuzuka H, Lau A, Wei W, Beroukhim R, Toker A. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell. 2014;56:595-607 pubmed publisher
  55. Aydin I, Melamed R, Adams S, Castillo Martin M, Demir A, Bryk D, et al. FBXW7 mutations in melanoma and a new therapeutic paradigm. J Natl Cancer Inst. 2014;106:dju107 pubmed publisher
  56. Kardos G, Dai M, Robertson G. Growth inhibitory effects of large subunit ribosomal proteins in melanoma. Pigment Cell Melanoma Res. 2014;27:801-12 pubmed publisher
  57. Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Mol Endocrinol. 2014;28:935-48 pubmed publisher
  58. Ram R, Mendiratta S, Bodemann B, Torres M, Eskiocak U, White M. RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression. Mol Cell Biol. 2014;34:2350-8 pubmed publisher
  59. Sengupta S, Jana S, Bhattacharyya A. TGF-?-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cell Signal. 2014;26:240-52 pubmed publisher
  60. Valdez B, Nieto Y, Murray D, Li Y, Wang G, Champlin R, et al. Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines. Exp Hematol. 2012;40:800-10 pubmed publisher